EDESA BIOTECH, INC. Other Receivables
EDESA BIOTECH, INC. (EDSA) had Other Receivables of $1.10 million as of 2022-09-30, per its 10-K filed 2022-12-16.
Discontinued › Notes › Nontrade Receivables
us-gaap:OtherReceivables · last filed 2022-12-16
- 2022-09-30: Other Receivables $1.10M.
- 2022-06-30: Other Receivables $1.10M.
- 2022-03-31: Other Receivables $1.10M.
- 2021-12-31: Other Receivables $2.63M.
| Period end | Other Receivables |
|---|---|
| 2022-09-30 | $1.10M 10-K · filed 2022-12-16 |
| 2022-06-30 | $1.10M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.10M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $2.63M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $3.03M 10-K · filed 2021-12-28 |
| 2021-06-30 | $3.99M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |